IGF1 and Alzheimer disease: Furthermore, elevated levels of secreted phosphoprotein I (SPPI), insulin-like growth factor 1 (IGF1), vascular endothelial growth factor receptor 1 (FLT1) and CD44 in both MetS and AD may also be treated as potential markers of the two conditions [115].